Balyasny Asset Management LLC Morphic Holding, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$26.64 - $40.31 $3.5 Million - $5.3 Million
131,521 Added 741.72%
149,253 $5.25 Million
Q4 2023

Feb 14, 2024
SELL
$19.95 - $31.0 $3.4 Million - $5.28 Million
-170,238 Reduced 90.57%
17,732 $512,000
Q3 2023

Nov 14, 2023
BUY
$21.33 - $59.42 $4.01 Million - $11.2 Million
187,970 New
187,970 $4.31 Million
Q3 2022

Nov 14, 2022
BUY
$22.23 - $33.37 $328,292 - $492,808
14,768 New
14,768 $418,000

Others Institutions Holding MORF

# of Institutions
8
Shares Held
4.7M
Call Options Held
0
Put Options Held
0
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email